4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001193125-26-297818
General Counsel sold 245 shares at $29.98 ($7,345)
- General Counsel acquired 680 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Winslow Garrett · General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-03 | Exercise or conversion : show line 1 in the form | +680 | 2,534 | D | ||
| 2026-07-06 | Sale : show line 2 in the form | −245 | $29.98 | $7,345 | 2,289 | D |
| Open-market sales · 245 sh · avg $29.98 · $7,345 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-03 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −680 | 640 | D |
Loading xslF345X06/ownership.xml…